Crewe Advisors LLC Myriad Genetics Inc Call Options Transaction History
Crewe Advisors LLC
- $695 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MYGN
# of Institutions
235Shares Held
90.1MCall Options Held
15.4KPut Options Held
18.2K-
Black Rock Inc. New York, NY15.2MShares$117 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$82.1 Million0.0% of portfolio
-
State Street Corp Boston, MA5.27MShares$40.6 Million0.0% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN4.73MShares$36.4 Million0.98% of portfolio
-
Wellington Management Group LLP Boston, MA4.59MShares$35.4 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $621M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...